Related Experiment Video

Updated: Jul 16, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Facilitating visitation for infants with prenatal substance exposure

Caroline Long Burry1, Lois Wright

  • 1School of Social Work, University of Maryland, 525 West Redwood Street, Baltimore, MD 21201, USA. cburry@ssw.umaryland.edu

Child Welfare
|February 20, 2007
PubMed

Insights

Permanency planning for infants exposed to substances during pregnancy is complex. This study details how child welfare workers can use supervised visits to support these infants and their families effectively.

Area of Science:

  • Child welfare
  • Pediatrics
  • Substance abuse treatment

Background:

  • Permanency planning for infants with prenatal substance exposure presents unique challenges.
  • Infant characteristics and parental substance use/relapse complicate care.
  • Visitation is a key tool for child welfare in determining and supporting permanency.

Purpose of the Study:

  • To describe the productive use of visitation for permanency planning.
  • To outline strategies for focusing visits on the specific needs of infants with prenatal substance exposure.

Main Methods:

  • Descriptive analysis of visitation practices.
  • Qualitative review of strategies for child welfare workers.

Main Results:

  • Visitation provides a critical opportunity to assess and support permanency planning.
  • Effective strategies involve skillfull focus on population-specific issues and needs.

Conclusions:

  • Optimizing visitation is essential for successful permanency planning for this vulnerable population.
  • Targeted strategies enhance the effectiveness of child welfare interventions during visits.

More Related Videos

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

Related Concept Videos

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...